119 related articles for article (PubMed ID: 11119561)
1. Cytosolic delivery and characterization of the TcdB glucosylating domain by using a heterologous protein fusion.
Spyres LM; Qa'Dan M; Meader A; Tomasek JJ; Howard EW; Ballard JD
Infect Immun; 2001 Jan; 69(1):599-601. PubMed ID: 11119561
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of the immediate early gene product RhoB by exoenzyme C3 from Clostridium limosum and toxin B from Clostridium difficile.
Huelsenbeck J; Dreger SC; Gerhard R; Fritz G; Just I; Genth H
Biochemistry; 2007 Apr; 46(16):4923-31. PubMed ID: 17397186
[TBL] [Abstract][Full Text] [Related]
3. Serine-71 phosphorylation of Rac1/Cdc42 diminishes the pathogenic effect of Clostridium difficile toxin A.
Schoentaube J; Olling A; Tatge H; Just I; Gerhard R
Cell Microbiol; 2009 Dec; 11(12):1816-26. PubMed ID: 19709124
[TBL] [Abstract][Full Text] [Related]
4. EhRho1, a RhoA-like GTPase of Entamoeba histolytica, is modified by clostridial glucosylating cytotoxins.
Majumder S; Schmidt G; Lohia A; Aktories K
Appl Environ Microbiol; 2006 Dec; 72(12):7842-8. PubMed ID: 17056697
[TBL] [Abstract][Full Text] [Related]
5. Glucosylation of Rho proteins by Clostridium difficile toxin B.
Just I; Selzer J; Wilm M; von Eichel-Streiber C; Mann M; Aktories K
Nature; 1995 Jun; 375(6531):500-3. PubMed ID: 7777059
[TBL] [Abstract][Full Text] [Related]
6. Cellular stability of Rho-GTPases glucosylated by Clostridium difficile toxin B.
Genth H; Huelsenbeck J; Hartmann B; Hofmann F; Just I; Gerhard R
FEBS Lett; 2006 Jun; 580(14):3565-9. PubMed ID: 16730714
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the enzymatic domain of Clostridium difficile toxin B reveals novel inhibitors of the wild-type toxin.
Spyres LM; Daniel J; Hensley A; Qa'Dan M; Ortiz-Leduc W; Ballard JD
Infect Immun; 2003 Jun; 71(6):3294-301. PubMed ID: 12761111
[TBL] [Abstract][Full Text] [Related]
8. The enzymatic domain of Clostridium difficile toxin A is located within its N-terminal region.
Faust C; Ye B; Song KP
Biochem Biophys Res Commun; 1998 Oct; 251(1):100-5. PubMed ID: 9790914
[TBL] [Abstract][Full Text] [Related]
9. Haemorrhagic toxin and lethal toxin from Clostridium sordellii strain vpi9048: molecular characterization and comparative analysis of substrate specificity of the large clostridial glucosylating toxins.
Genth H; Pauillac S; Schelle I; Bouvet P; Bouchier C; Varela-Chavez C; Just I; Popoff MR
Cell Microbiol; 2014 Nov; 16(11):1706-21. PubMed ID: 24905543
[TBL] [Abstract][Full Text] [Related]
10. Difference in protein substrate specificity between hemorrhagic toxin and lethal toxin from Clostridium sordellii.
Genth H; Hofmann F; Selzer J; Rex G; Aktories K; Just I
Biochem Biophys Res Commun; 1996 Dec; 229(2):370-4. PubMed ID: 8954906
[TBL] [Abstract][Full Text] [Related]
11. Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470.
Huelsenbeck J; Dreger S; Gerhard R; Barth H; Just I; Genth H
Infect Immun; 2007 Feb; 75(2):801-9. PubMed ID: 17145947
[TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile toxins: mechanism of action and role in disease.
Voth DE; Ballard JD
Clin Microbiol Rev; 2005 Apr; 18(2):247-63. PubMed ID: 15831824
[TBL] [Abstract][Full Text] [Related]
13. Rho GTPases as targets of bacterial protein toxins.
Aktories K; Schmidt G; Just I
Biol Chem; 2000; 381(5-6):421-6. PubMed ID: 10937872
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary study of LFn-MAGE3 fusion protein expression and its biological function].
Kong YR; Fu L; Guo Q; Yu T; Yu CM; Chen W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Mar; 22(2):181-4. PubMed ID: 16507254
[TBL] [Abstract][Full Text] [Related]
15. Difference in F-actin depolymerization induced by toxin B from the Clostridium difficile strain VPI 10463 and toxin B from the variant Clostridium difficile serotype F strain 1470.
May M; Wang T; Müller M; Genth H
Toxins (Basel); 2013 Jan; 5(1):106-19. PubMed ID: 23344455
[TBL] [Abstract][Full Text] [Related]
16. Prevention of the cytopathic effect induced by Clostridium difficile Toxin B by active Rac1.
Halabi-Cabezon I; Huelsenbeck J; May M; Ladwein M; Rottner K; Just I; Genth H
FEBS Lett; 2008 Nov; 582(27):3751-6. PubMed ID: 18848548
[TBL] [Abstract][Full Text] [Related]
17. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function.
Jank T; Giesemann T; Aktories K
Glycobiology; 2007 Apr; 17(4):15R-22R. PubMed ID: 17237138
[TBL] [Abstract][Full Text] [Related]
18. Trans-10, cis-12 conjugated linoleic acid modulates phagocytic responses of canine peripheral blood polymorphonuclear neutrophilic leukocytes exposed to Clostridium difficile toxin B.
Kang JH; Lee GS; Jeung EB; Yang MP
Vet Immunol Immunopathol; 2009 Aug; 130(3-4):178-86. PubMed ID: 19269037
[TBL] [Abstract][Full Text] [Related]
19. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile.
Dingle T; Wee S; Mulvey GL; Greco A; Kitova EN; Sun J; Lin S; Klassen JS; Palcic MM; Ng KK; Armstrong GD
Glycobiology; 2008 Sep; 18(9):698-706. PubMed ID: 18509107
[TBL] [Abstract][Full Text] [Related]
20. Identification of the cellular receptor for anthrax toxin.
Bradley KA; Mogridge J; Mourez M; Collier RJ; Young JA
Nature; 2001 Nov; 414(6860):225-9. PubMed ID: 11700562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
